Featured Post
Meet CurifyLabs' CEO, Charlotta Topelius
Charlotta’s story on… unlocking a new era for compounding pharmacies
Interview with Erik Haeffler, CEO, APL
Interview with Erik Haeffler on APL's role in developing personalized medicines for patients with unique needs using innovative CSS-technology.
How 3D Printing is Transforming Pharmaceuticals into More Precise, Effective Treatments
In this recent article, the future of 3D printed medicine in personalization of treatments is discussed. Here are some snap shots from the article.
Mass Customization of Medicines
Mass customization is required for optimal treatments of the future. This excellent article by Siiskonen, Malmqvist and Folestad (2021) describes the potentoal of mass customization.
Meet the team - interview with our CEO Charlotta
I’m a serial entrepreneur with a commercial background and I really like to learn new things and think outside of the box.
Potential Risks of Pharmacy Compounding
Why do we need quality assurance for pharmacy compounding in the future?
.jpg)
Introducing Our Team - Interviewing Niklas Sandler Topelius
Meet Niklas Sandler Topelius, the inventor of Curify's technology!